Back to Webinars

BRCA and Beyond – Hereditary Risk for Cancers of the Breast, Ovary, Prostate, and Pancreas

Thursday, November 6, 2025
3:00am PST
1 hour
C.E.U.: 1 Category 1 Contact Hour
P.A.C.E.: 1 Unit

This webinar will review both broad concepts and key details of genes associated with hereditary risk of breast, ovary, prostate, and pancreas cancer. Familiarity with genes beyond BRCA1 and BRCA2 is important for comprehensive cancer genetic testing and can inform recommendations for cancer screening, risk-reduction, and treatment. These genes include ATM, BARD1, BRIP1, CHEK2, PALB2, RAD51C, and RAD51D. The cancer risks associated with inherited pathogenic variants (PVs) in these genes vary, introducing important nuances into risk assessment and counseling regarding medical interventions.

Level of instruction: intermediate

Explore Our Tests Patient Billing Billing CARE  

699dd4c3b3231845853513
Caitlin Reid
Genomic Science Liaison at Ambry Gentics 
Caitlin Reid, CGC, is a certified Genetic Counselor and Genomic Science Liaison at Ambry Genetics. She serves as a clinical liaison for the field team to educate health care providers and key opinion leaders on genetic testing and genomic medicine. Caitlin previously worked as an Oncology Genetic Counselor at the University of Iowa in the […]

Caitlin Reid, CGC, is a certified Genetic Counselor and Genomic Science Liaison at Ambry Genetics. She serves as a clinical liaison for the field team to educate health care providers and key opinion leaders on genetic testing and genomic medicine. Caitlin previously worked as an Oncology Genetic Counselor at the University of Iowa in the Holden Comprehensive Cancer center. Caitlin received her Bachelor of Science degree in Biology with a concentration in cell and developmental biology from the University of Iowa. She earned her Master of Science degree in Genetic Counseling from the University of Michigan in 2018 and is certified by the American Board of Genetic Counseling (ABGC).